Metastasis accounts for the vast majority of cancer-related deaths, yet the molecular mechanisms that drive metastatic spread remain poorly understood. Here we report that Tks5, which has been linked to the formation of proteolytic cellular protrusions known as invadopodia, undergoes an isoform switch during metastatic progression in a genetically engineered mouse model of lung adenocarcinoma. Nonmetastatic primary tumor-derived cells predominantly expressed a short isoform, Tks5 short , while metastatic primary tumor-and metastasis-derived cells acquired increased expression of the full-length isoform Tks5 long . This elevation of Tks5 long to Tks5 short ratio correlated with a commensurate increase in invadopodia activity in metastatic cells compared with nonmetastatic cells. Further characterization of these isoforms by knockdown and overexpression experiments demonstrated that Tks5 long promoted invadopodia in vitro and increased metastasis in transplant models and an autochthonous model of lung adenocarcinoma. Conversely, Tks5 short decreased invadopodia stability and proteolysis, acting as a natural dominant-negative inhibitor to Tks5 long . Importantly, high Tks5 long and low Tks5 short expressions in human lung adenocarcinomas correlated with metastatic disease and predicted worse survival of early stage patients. These data indicate that tipping the Tks5 isoform balance to a high Tks5 long to Tks5 short ratio promotes invadopodia-mediated invasion and metastasis.
[Keywords: Tks5; invadopodia; metastasis; lung adenocarcinoma; non-small-cell lung cancer; mouse model] Supplemental material is available for this article. Received October 18, 2012; revised version accepted June 19, 2013. Despite the high rates of mortality associated with metastatic lung cancer (Keshamouni et al. 2009; Siegel et al. 2013) , the molecular mechanisms underlying disease progression remain incompletely understood. Metastasis accounts for the vast majority of all lung cancer fatalities, as even 30%-50% of early stage patients who undergo surgical resection eventually succumb to metastatic relapse, and patients with metastatic disease are almost always incurable (Keshamouni et al. 2009 ). The development of more effective therapeutic interventions for this disease will rely on improving our understanding of metastasis at the molecular level.
Tks5 (also known as Sh3pxd2a) has been previously implicated in promoting metastasis because of its role in invasive cellular structures known as invadopodia (Courtneidge 2012) . Invadopodia are actin-rich, proteolytic membrane protrusions that were initially identified in Src-transformed mouse embryonic fibroblasts (Chen et al. 1984; Tarone et al. 1985) and later observed in a variety of cultured human cancer cells, including breast cancer, melanoma, and head and neck squamous cell carcinoma (Seals et al. 2005; Bowden et al. 2006; Clark et al. 2007) . While invadopodia formation is spontaneous in some cancer cells in culture, it can be further stimulated by activating integrin b1 and receptors for epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) (Nakahara et al. 1998; Yamaguchi et al. 2005; Philippar et al. 2008; Eckert et al. 2011) . These cellular ''invasive feet'' have been demonstrated to produce a variety of proteases, including metalloproteases (MMP2, MMP9, MT1-MMP, and the ADAM family of sheddases) and serine proteases (seprase and uPAR) (Linder 2007) , and are capable of digesting various components of the extracellular matrix in vitro (Kelly et al. 1994 ). Given their proteolytic capabilities, invadopodia are thought to facilitate metastasis by enabling tumor cells to breach the basement membrane, degrade the extracellular matrix, and invade into the stroma during the intravasation and extravasation steps of the metastatic cascade (Murphy and Courtneidge 2011) . In fact, it has been proposed that invadopodia in cancer cells are a co-opted and dysregulated version of normal cellular structures known as podosomes that are found in untransformed cells such as osteoclasts, macrophages, dendritic cells, endothelial cells, and smooth muscle cells (Murphy and Courtneidge 2011) . Although it is still unclear whether invadopodia have any physiological function in metastatic invasion during natural tumor progression (Linder 2009; Sibony-Benyamini and Gil-Henn 2012) , animal transplant studies and intravital imaging have provided some in vivo evidence for a role for invadopodia in mediating metastasis (Philippar et al. 2008; Gligorijevic et al. 2012) .
Tks5 is an important component of invadopodia and mediates invadopodia formation by acting as a Srcdependent scaffolding protein (Lock et al. 1998) . Upon phosphorylation by Src, the N-terminal phox (PX) homology domain of Tks5 is thought to be released from intramolecular interactions and becomes free to bind membrane phosphoinositides, including PI(3,4)P2, thereby localizing Tks5 to the site of invadopodia formation (Abram et al. 2003; Oikawa et al. 2008) . Tks5 also contains five C-terminal Src homology 3 (SH3) domains, which recruit effector proteins (including AFAP-110, cortactin, and ADAM metalloproteases) to initiate actin polymerization and matrix degradation (Abram et al. 2003; Crimaldi et al. 2009 ). Knockdown of Tks5 (targeting all isoforms simultaneously) abrogates invadopodia formation and proteolytic function in cultured human breast cancer and melanoma cells (Seals et al. 2005 ) and reduces lung metastasis formation by Src-transformed NIH-3T3 mouse embryonic fibroblasts and Ras-transformed human mammary epithelial cells after intravenous injection or subcutaneous transplantation (Blouw et al. 2008; Eckert et al. 2011) .
Despite the evidence that Tks5 is important for invadopodia formation in cell lines, its contribution to the metastatic process in naturally evolving tumors has not been elucidated. Moreover, previous studies have not accounted for the presence of the two functionally distinct isoforms (which we termed Tks5 long and Tks5 short ) that we characterize in this study. These two Tks5 variants were first detected by immunoblotting in Src-transformed NIH-3T3 cells when Tks5 was initially identified (Lock et al. 1998) ; however, no subsequent functional studies have taken into account the existence of these isoforms. Therefore, the distinct roles of Tks5 long and Tks5 short in invadopodia function and cancer invasion are unknown.
Here we report that Tks5 long and Tks5 short play distinct and opposing roles in regulating invadopodia-mediated invasion in lung adenocarcinoma. We show that metastatic primary tumor-and metastasis-derived cells acquired an elevated ratio of Tks5 long to Tks5 short expression and a commensurate increase in invadopodia activity compared with nonmetastatic cells. We further demonstrate that the ratio of Tks5 long to Tks5 short expression regulates invadopodia function in vitro and influences metastatic potential in transplant models and a genetically engineered mouse model of lung cancer. Finally, we provide evidence that the relative expression of Tks5 long and Tks5 short represents an important prognostic factor in human lung cancer. These results highlight the isoformdependent roles of Tks5 in invadopodia and metastasis.
Results
Metastatic and nonmetastatic lung adenocarcinoma cells exhibit differential expression of Tks5 long and Tks5 short
To better characterize the cell state changes and molecular alterations that accompany tumor progression and metastasis in lung adenocarcinoma, we recently developed a K-ras LSL-G12D/WT ; p53 flox/flox mouse model for studying metastatic and nonmetastatic primary tumors (Winslow et al. 2011) . This model harbors genetic mutations frequently found in human lung adenocarcinoma (Rodenhuis et al. 1988; Takahashi et al. 1989 ) and closely recapitulates the histopathological progression of the human disease (Jackson et al. 2005) . Although these mice develop multiple K-ras G12D , p53 À/À lung tumors after inhalation of lentivirus expressing Cre recombinase, only a subset of tumors eventually acquire full metastatic potential, suggesting that progression to metastasis requires additional genetic and/or epigenetic events. Importantly, this model allows the identification of metastatic versus nonmetastatic primary tumors, as the metastases that form in these mice can be matched to their primary tumor of origin based on the common lentiviral integration site in their genome. Thus, primary tumors (T Met ) that have given rise to metastatic lesions can be distinguished from primary tumors for which no metastasis was found (T nonMet ). Cell lines derived from these T Met and T nonMet tumors were examined for their gene expression profiles via exon microarrays, which identified expression alterations in various genes, including Nkx2-1 and Hmga2, that were associated with metastatic progression (Winslow et al. 2011) .
To identify gene isoform expression changes that could be caused by alternative splicing or differential promoter utilization in our collection of autochthonous tumorderived T nonMet and T Met cells, we developed an algorithm that allowed us to query our exon array data for changes in isoform usage. The most striking result from this analysis was a change in Tks5 isoform expression between T nonMet and T Met cells (Supplemental Fig. S2 ). We identified two Tks5 isoforms by referencing sequences published on the University of California at Santa Cruz genome browser (http://genome.ucsc.edu, assembly NCBI37/mm9, gene Sh3pxd2a): Tks5 long , which contains exons 1-15, and Tks5 short , which contains a distinct 59 sequence from intron 7 followed by exons 8-15 (Fig. 1A) . Both transcripts encode five SH3 domains in the C terminus, but only Tks5 long contains the N-terminal PX homology domain (Fig. 1A) .
We confirmed the differential expression of Tks5 long and Tks5 short in T nonMet and T Met cells by performing isoform-specific quantitative RT-PCR (qRT-PCR) on a panel of three T nonMet cell lines as well as five T Met cell lines and their five matching metastasis cell lines (Met). Consistent with the microarray data, Tks5 long transcript levels were, on average, fourfold higher in T Met /Met cells compared with T nonMet cells, while Tks5 short was transcribed at a similar level between T Met /Met and T nonMet cells (Fig. 1B) . As a result, the ratio of Tks5 long to Tks5 short was, on average, sixfold higher in T Met /Met cells than T nonMet cells (Fig. 1B) . Consistent with the mRNA expression patterns, the ratio of Tks5 long to Tks5 short proteins (150 kDa and 140 kDa, respectively) is higher in T Met cells compared with T nonMet cells (Fig. 1C) .
Interestingly, despite this increase in Tks5 long transcripts, because Tks5 long only accounted for a fraction of total Tks5 expression, the levels of total Tks5 transcript did not vary significantly between T nonMet and T Met /Met cell lines in our exon microarray or in our qRT-PCR analysis using primers targeting a common region shared by Tks5 long and Tks5 short transcripts (Fig. 1B) . Thus, the T nonMet and T Met /Met cell lines could be distinguished by their Tks5 long expression or Tks5 long to Tks5 short ratio but not by total Tks5 level. 59 RACE and H3K4me3 chromatin immunoprecipitation sequencing (ChIP-seq) analyses suggest that the two isoforms are transcribed from distinct promoters (data not shown).
Expression of Tks5 long and Tks5 short in T nonMet and T Met cells correlates with invadopodia formation and function Given the differences in Tks5 isoform levels between T Met and T nonMet cells and the previously reported role of Tks5 in mediating invadopodia activity, we compared three T nonMet and four T Met cell lines for invadopodia formation and function. To measure invadopodia formation, we performed immunofluorescence staining to detect the colocalization of two essential invadopodia components: cortactin and F-actin ( Fig. 2A) . T Met cells, which have a higher Tks5 long to Tks5 short ratio, displayed Tks5 isoform expression contributes to metastasis a higher frequency of colocalized cortactin and F-actin than T nonMet cells (Fig. 2B ). To measure invadopodia function, we examined invadopodia-mediated proteolysis in T nonMet and T Met cells by culturing them on a thin layer of FITC-labeled gelatin. The degraded areas can be observed by fluorescence microscopy as FITC-negative patches that frequently coincide with cortactin/F-actinstained invadopodia foci ( Fig. 2A) . The gelatin degradation assay is a more sensitive method to measure invadopodia activity compared with cortactin/F-actin immunofluorescence staining because the effect of degradation is cumulative over time, while the presence of invadopodia is transient. Quantification of the degradation area showed a strong correlation between the proteolytic capability of these T nonMet and T Met cells and their ratio of Tks5 long to Tks5 short expression: T Met cells with higher Tks5 long to Tks5 short ratios were more proteolytic on the gelatin matrix compared with T nonMet cells (Fig. 2C ). Importantly, we did not observe significant differences in other invadopodia components at either the total gene expression or isoform level by exon array analysis (analyzed for Tks4, Src, Cortactin, Afap110, p190 RhoGAP, Arg, N-WASP, Arp2/3 complex subunits, Wave1, Cdc42, Cofilin, Gelsolin, MT1-MMP, MMP2, MMP9, ADAM12, ADAM15, and ADAM19) or the protein phosphorylation level by Western blot (analyzed for Src) (data not shown). Taken together, these observations suggest that an increased ratio of Tks5 long to Tks5 short is associated with the enhanced invadopodia formation and function that we observed in T Met cells compared with T nonMet cells.
Knockdown of Tks5 long impairs invadopodia activity and metastasis formation
Since the distinct functions of Tks5 long and Tks5 short in invadopodia have not been previously reported, we tested whether Tks5 long was specifically required for invadopodia formation and function in two T Met cell lines. Stable RNAi-mediated depletion of Tks5 long using two isoform-specific shRNAs reduced Tks5 long expression in T Met cells by 55%-65% without a significant effect on Tks5 short (Fig. 3A ,B). Tks5 long knockdown impaired the ability of T Met cells to form invadopodia as measured by immunofluorescence staining for cortactin/F-actin foci ( Fig. 3C,D ; Supplemental Fig. S3A ,B). These T Met -shTks5 long cells also exhibited significantly reduced extracellular matrix proteolysis capability when cultured on FITC gelatin ( Fig. 3C ,E; Supplemental Fig. S3A ,C). Because these observations were consistent for both shTks5 long shRNAs, it is unlikely that they were the results of offtarget effects. Collectively, these data indicate that Tks5 long is necessary for invadopodia activity in metastatic lung cancer cells.
To determine whether the effects of Tks5 long knockdown on invadopodia activity in vitro translate to the inhibition of metastatic ability in vivo, we transplanted T Met -shTks5 long cells subcutaneously into athymic nude mice to assess the metastatic potential of tumor cells. T Met cells with Tks5 long knockdown exhibited a significantly diminished ability to disseminate from the subcutaneous site and form lung tumor nodules compared with parental cells 8 wk after subcutaneous injection (Fig. 3F) . Of note, the sizes of the subcutaneous tumors were comparable between the two mouse cohorts, suggesting that loss of Tks5 long expression had no effect on primary tumor growth (Supplemental Fig. S3D ). Furthermore, in a separate experiment, we transplanted cells intrasplenically to assess their ability to extravasate and colonize the liver after draining into the hepatic portal vein from the spleen. Consistent with data from the subcutaneous transplant experiment, intrasplenically injected T Met -shTks5 long cells showed a substantially reduced ability to form liver nodules 3 wk after transplantation compared with controls (Fig. 3G) . Importantly, inefficient liver colonization by T Met -shTks5 long cells was not a result of reduced cell proliferation or increased apoptosis, as the infrequent liver nodules that were formed by T Met -shTks5 long cells displayed similar mitotic and apoptotic indices compared with parental cells (Supplemental Fig. S3E,F) . These experiments suggest that Tks5 long -induced invadopodia are not only important for promoting cell invasion during intravasation at the primary site, but also required for extravasation and/or colonization at the metastatic sites, potentially by facilitating metastatic cell exit from blood vessels and/or invasion at secondary sites.
Increased Tks5 long expression promotes invadopodia activity and metastasis formation
To ask whether exogenous expression of Tks5 long alone is sufficient to enhance invadopodia formation and function in T nonMet cells, we generated a lentivirus that allows doxycycline-inducible expression of Flag-tagged Tks5 long (Fig. 4A) . Increased expression of Tks5 long in two independent T nonMet cell lines promoted invadopodia formation compared with parental cells as measured by immunofluorescence staining for foci of cortactin/F-actin colocalization ( Fig. 4B,C; Supplemental Fig. S4A ). Moreover, these cells also displayed a dramatic sixfold to 14-fold increase in matrix proteolysis in the FITC gelatin degradation assay (Fig. 4B,D; Supplemental Fig. S4B) . Our data thus demonstrate that changing the Tks5 long to Tks5 short ratio by increasing Tks5 long expression is sufficient to promote invadopodia formation and function in nonmetastatic lung adenocarcinoma cells.
We then sought to determine whether Tks5 long also facilitates tumor metastasis in vivo. To test this in a physiologically relevant model of tumor progression, we infected K-ras LSL-G12D/WT ; p53 flox/flox ; Rosa26-LSLTdTomato; CCSP-rtTA mice with a PGK-Cre/TRETks5 long lentivirus (Fig. 4E) . Inhalation of the virus initiates RFP-positive lung tumors through the concomitant activation of oncogenic K-ras and deletion of p53. Infected mice were then fed with a doxycycline diet starting at 4 wk post-infection to induce Flag-tagged Tks5 long expression, allowing us to study the effects of Tks5 long specifically on tumor progression and not initiation. We confirmed inducible expression of our construct through detection of doxycycline-and rtTA-dependent expression of Flag-tagged Tks5 long in these lung tumors (Supplemental Fig. S4C ). At 6 mo post-infection, although widespread distant metastases had not yet developed, we observed a significant acceleration in primary tumor progression in Tks5 long mice (n = 9 mice; 221 tumors) compared with the control mice (n = 14 mice; 397 tumors): Tks5 long tumors had a smaller proportion of low-grade tumors and a commensurate increase in high-grade lesions (Supplemental Fig. S4D ). These high-grade tumors were invasive into stromal tissues surrounding the blood vessels and were thus categorized as grade 4 lesions (Supplemental Fig. S4E ). ; CCSP-rtTA mice were infected with a PGK-Cre/TRETks5 long lentivirus. The Cre recombinase initiates lung adenocarcinomas upon infection. Doxycycline diet later induced Tks5 long expression in these tumors to study the effects of Tks5 long on tumor progression without affecting tumor initiation. (F) Examples of distant metastases observed in mice with increased Tks5 long expression. All tumors are RFP-positive because of a Rosa26-LSL-TdTomato allele in the mice. (BF) Bright field. (G) Mice with increased Tks5 long expression (n = 15) developed more distant metastases compared with control mice (n = 8). P < 0.03, x 2 test; P < 0.04, Fisher's exact test, two tailed. (H) Mice with increased Tks5 long expression (n = 15) developed more metastases overall (including distant metastases and pleural metastases) compared with control mice (n = 8). P < 0.003, x 2 test; P < 0.008, Fisher's exact test, two tailed.
Tks5 isoform expression contributes to metastasis
Consistent with these observations, at 8 mo postinfection, when mice had developed both pleural metastases and distant metastases in the liver, kidneys, and distant lymph nodes (Fig. 4F) , Tks5 long -expressing mice developed significantly more distant metastases (11 of 15 mice) than the control group (two of eight mice; P < 0.05 by both x 2 test and Fisher's exact test) (Fig. 4G ). In addition, 15 of 15 Tks5 long mice developed pleural metastases and/or distant metastases, while four of eight mice in the control group remained metastasis-free (P < 0.003 by x 2 test and P < 0.008 by Fisher's exact test) (Fig. 4H) . Importantly, we did not observe any significant difference in the primary lung tumor sizes and total lung tumor burden in the Tks5 long mice versus control mice (Supplemental Fig. S4F,G) , suggesting that the effect of Tks5 long on tumor progression and metastasis was not a consequence of increasing the rate of tumor growth.
Collectively, these data from this mouse model indicate that Tks5 long plays an important role in promoting metastasis in vivo and are consistent with our in vitro evidence that Tks5 long promotes invadopodia-mediated invasion. Whether tumor progression can be further stimulated by other mechanisms-including, for example, growth factor shedding during invadopodia-mediated degradation of the extracellular matrix-remains an open possibility and will be addressed in future studies.
Elevated expression of Tks5 short reduces gelatin matrix degradation and invadopodia lifetime
In addition to modulating Tks5 long expression, the Tks5 long to Tks5 short ratio can also be altered by increasing the expression of the less well-studied isoform Tks5 short . While Tks5 short levels in T nonMet and T Met /Met cells were similar, we were interested whether Tks5 short could also participate in regulating invadopodia activity. Although we attempted to knock down Tks5 short by shRNA, this approach proved to be challenging, since the unique sequence in the Tks5 short transcript is very short. Therefore, we chose to infect T Met cells with a lentivirus that allowed doxycycline-inducible expression of HA-tagged Tks5 short (Fig. 5A) . Interestingly, two independent T Met cell lines with exogenous Tks5 short expression both had drastically reduced gelatin matrix proteolysis (Fig. 5B) , suggesting that Tks5 short may act in a dominant-negative manner over Tks5 long in regulating invadopodia activity.
We additionally determined the localization of Tks5 short by using an antibody specific for the HA tag and found that HA-Tks5 short exhibited a diffuse localization in T MetTks5 short cells (Fig. 5C ). This distribution is in contrast to that of endogenous Tks5 in T Met cells stained with a panTks5 antibody, where the protein (presumably the dominant Tks5 long isoform in T Met cells) is concentrated at foci of cortactin/F-actin colocalization (Fig. 5C ). The diffuse distribution of Tks5 short suggests that it cannot localize to invadopodia foci on the cell membrane, conceivably due to lack of a PX homology domain.
Moreover, even though cortactin/F-actin-positive foci of invadopodia could be observed in T Met -Tks5 short cells (Fig. 5C ), when we measured the lifetime of invadopodia in these cells using time-lapse fluorescence imaging, they exhibited shortened invadopodia lifetime compared with parental T Met cells (Fig. 5D) . Previous studies have shown that nascent invadopodia remain nonproteolytic for at least 1 h before maturing into fully functional invadopodia that are capable of mediating degradation (Yamaguchi et al. 2005; Oser et al. 2009 ). Thus, our data suggest that Tks5 short may destabilize invadopodia and interfere with their maturation into a proteolytic state. Hence, the ratio between Tks5 short and Tks5 long , rather than the absolute levels of either isoform or total Tks5, appears to be important for invadopodia-mediated cell invasion. High expression of Tks5 long and low expression of Tks5 short correlate with metastatic progression and poor survival in lung adenocarcinoma patients
We next explored whether a high Tks5 long to Tks5 short ratio correlates with tumor progression and metastasis in human lung cancer. For this purpose, we analyzed RNA sequencing (RNA-seq) data from lung adenocarcinoma patients deposited in The Cancer Genome Atlas (TCGA) for the expression ratio of Tks5 long to Tks5 short . The human Tks5 short transcript homologous to mouse Tks5 short was the most abundant isoform alternative to Tks5 long in these lung tissues (data not shown), although additional transcripts with slight variations exist in other tissue types (S. Courtneidge, pers. comm.; http://genome.ucsc.edu, assembly GRCh37/hg19, gene Sh3pxd2a). Importantly, while the expression patterns of Tks5 long and Tks5 short in these lung adenocarcinomas were diverse, there was a trend toward high Tks5 long to Tks5 short expression ratios in patients with stage III and IV disease (characterized by metastatic invasion in the thoracic cavity and distant organs, respectively; n = 59) compared with patients with stage IA disease (characterized by a single, small, localized lesion without detectible metastases; n = 57; P < 0.009 by x 2 test and P < 0.013 by Fisher's exact test) (Fig. 6A ), suggesting that high Tks5 long and low Tks5 short expression contributes to promoting metastatic progression.
In addition, we examined Tks5 long and Tks5 short expression in an independent cohort of 102 patients with stage I/II lung adenocarcinoma from the University of Michigan. Interestingly, we observed that higher Tks5 long expression and lower Tks5 short expression correlated with worse disease-free survival and overall survival by KaplanMeier analysis ( Fig. 6B; Supplemental Fig. S5 ) and reflected poor prognosis in a multivariate analysis by the Cox proportional hazard model after adjustment for gender, age, stage, and tumor differentiation state (Table 1; Supplemental Table S1 ). Importantly, total expression of Tks5 did not demonstrate any survival correlation or prognostic values in these analyses ( Fig. 6B ; Table 1 ; Supplemental Fig. S5 ; Supplemental Table S1 ), suggesting that the distinction between Tks5 isoforms is critical in analyzing these clinical data. As disease-free survival and, to a lesser extent, overall survival reflect the rate of post-resection tumor relapse and thus, most likely, the magnitude of early micrometastatic spread prior to surgery, our data are consistent with the conclusion that Tks5 long promotes metastasis in human lung cancer, while Tks5 short exerts the opposite effect, and a shift in the balance of the two isoforms may influence the clinical outcomes in lung adenocarcinoma patients. In addition, Tks5 long and Tks5 short may serve as prognostic factors for identifying high-risk patients with early stage disease who may benefit from adjuvant treatment following tumor resection.
Discussion
Metastasis accounts for the vast majority of cancer related deaths, underscoring the need for a better understanding of the molecular mechanisms that enable tumor cells to escape from their primary site and spread to other parts of the body. In this study, we report a shift in the isoform expression of an invadopodia component, Tks5, that helps explain the increased invasiveness of metastatic cells during lung adenocarcinoma progression. Our data indicate that as primary tumors progress from a nonmetastatic state (T nonMet ) to a metastatic state (T Met ) and eventually form secondary lesions (Met), tumor cells acquire an increase in Tks5 long to Tks5 short expression, despite a lack of significant increase in total Tks5 expression. Using functional experiments in cultured cells and mouse models, we demonstrate distinct and opposing roles for Tks5 long and Tks5 short . Tks5 long promotes invadopodia activity and metastasis formation, as knockdown of Tks5 long impairs invadopodia function in vitro and metastasis formation in vivo, while elevated expression of Tks5 long has the opposite effects. Tks5 short , on the other hand, acts as a negative regulator of invadopodia function, as increased expression of Tks5 short interferes with invadopodia stability and inhibits gelatin proteolysis. Hence, it is the balance of Tks5 long and Tks5 short expression, rather than total Tks5 level, that appears to be important for metastatic invasion. Consistent with these functional analyses, our clinical data demonstrate that a high level of Tks5 long expression and a low level of Tks5 short expression (but not total Tks5 expression) correlate with Figure 6 . A high Tks5 long to Tks5 short ratio correlates with metastasis and poor survival in lung adenocarcinoma patients. (A) Ratio of Tks5 long to Tks5 short expression in primary lung adenocarcinomas of stage IA patients (n = 57) and stage III/IV patients (n = 59). P-value < 0.009, x 2 test; P < 0.013, Fisher's exact test, two-tailed. (B) Five-year disease-free survival of stage I/II lung adenocarcinoma patients correlates with Tks5 long and Tks5 short expression but not total expression of Tks5. Patients (n = 102) were divided into two groups based on expression level (high, top two-thirds; low, bottom one-third). All P-values are from log-rank test. Tks5 isoform expression contributes to metastasis metastatic progression in lung adenocarcinoma patients and predict poor survival of patients with early stage disease. These experiments provide insight into the roles of Tks5 isoforms in metastasis. Previous studies have demonstrated a role of Tks5 in invadopodia and invasion (Seals et al. 2005; Blouw et al. 2008) ; however, the specific roles of its isoforms have not been defined. Our data revise the current notion that Tks5 generally promotes invadopodia and metastasis and support a model in which Tks5 long acts to promote invadopodia formation by binding to the cellular membrane and recruiting effector proteins for actin polymerization and protease secretion, while Tks5 short acts to regulate invadopodia function by interfering with their stability and maturation. A shift in the balance of Tks5 long and Tks5 short expression in cancer cells may have a profound impact on tumor progression. While our data indicate that Tks5 short interferes with invadopodia stability, the specific mechanism of this regulation remains to be elucidated. It is conceivable that Tks5 short acts by sequestering invadopodia components away from the cell membrane via its multiple SH3 domains, proline-rich regions, and phosphorylation sites. Previous biochemical assays have shown that these functional domains of Tks5 bind to multiple invadopodia components, including N-WASP, Nck, and ADAM family metalloproteases (Abram et al. 2003; Oikawa et al. 2008; Stylli et al. 2009 ). Whether these protein interactions mediate the inhibitory function of Tks5 short in invadopodia deserves future investigation. In addition, given the differential isoform expression of Tks5 in metastatic and nonmetastatic tumors, it will be of great interest to identify the regulatory mechanism of this isoform switch. Preliminary data from our 59 RACE and H3K4me3 ChIPseq analyses suggest that the two isoforms are transcribed from distinct promoters (C Li, unpubl.) . Future work will dissect the regulatory mechanisms of promoter choice that lead to the increased expression of Tks5 long during tumor progression.
This study also underscores the in vivo role of invadopodia as critical mediators of metastasis in natural tumor progression. While previous studies have provided important evidence for a role of invadopodia in mediating metastatic invasion by using cell culture-based invasion assays and transplant models (Seals et al. 2005; Blouw et al. 2008; Philippar et al. 2008; Eckert et al. 2011; Gligorijevic et al. 2012) , these experimental systems often do not fully recapitulate natural tumor progression and metastatic spread. Here we further establish the role of invadopodia in promoting metastasis in vivo by using an autochthonous mouse model of metastatic lung cancer. Our data thus help address the question of whether invadopodia play a physiologically relevant role in metastasis in vivo (Linder 2009; Sibony-Benyamini and Gil-Henn 2012) . The data presented by our study and others provide a mechanism that explains one of the ways in which tumor cells might overcome the multiple physical barriers presented by stromal tissues, the extracellular matrix, and endothelial cells during the intravasation, extravasation, and colonization steps of metastasis.
Interestingly, while the gain of Tks5 long expression in both T Met and Met cells in our lung adenocarcinoma model suggests that invadopodia function in both the invasion/intravasation step at the primary tumor and the extravasation/colonization step at the metastatic site, the specific contribution of invadopodia to each step of the metastasis cascade may be context-dependent and cell type-dependent. Whereas knockdown of Tks5 long in lung adenocarcinoma cells (this study) and knockdown of total Tks5 in Ras-transformed mammary epithelial cells (Eckert et al. 2011 ) diminished the number of metastases formed, similar total Tks5 knockdown experiments in Src-transformed mouse embryonic fibroblasts did not lead to more metastases but an increase in the volume and vascularization of metastatic nodules (Blouw et al. 2008) . Thus, the specific contribution of invadopodia to each step of the invasion-metastasis cascade in different cancer types remains to be further dissected in the future.
In addition, this study carries clinical implications for lung cancer patients. Previous clinical studies of another invadopodia component, cortactin, indicate that its elevated expression and dysregulated cellular localization correlate with poor survival in laryngeal carcinoma and lung adenocarcinoma, respectively, underlining the relevance of invadopodia activity in predicting clinical outcomes (Gibcus et al. 2008; Hirooka et al. 2011) . Consistent with these studies, our data show that a high level of Tks5 long expression and a low level of Tks5 short expression correlate with metastatic progression of lung adenocarcinoma patients and predict poor survival of patients with early stage disease, suggesting that the Tks5 long to Tks5 short ratio may serve as a prognostic marker for assessing the metastatic potential of primary tumors and for identifying early stage patients who bear higher risks for metastasis and may benefit from adjuvant therapy after tumor resection. Furthermore, future development of molecular therapeutic strategies that inhibit Tks5 long function or strengthen Tks5 short activity could potentially help inhibit metastatic progression.
Finally, this study demonstrates the value of mouse models and their derivative cell lines in allowing molecular characterization of the cell state changes that accompany tumor progression and metastasis and is representative of recent developments of animal models for lung adenocarcinoma (Jackson et al. 2005; Politi et al. 2006; Dankort et al. 2007; Ji et al. 2007 ). Importantly, our approach demonstrates that in order to fully understand the metastatic process, analysis of gene expression at the isoform level in addition to the total gene expression level is important. Given the lethal effects of the metastatic phase of cancer, a deeper insight into the molecular determinants of metastasis will have a significant impact on cancer mortality and morbidity.
Materials and methods

Cell lines
T nonMet , T Met , and Met cell lines were derived from autochthonous tumors in K-ras LSL-G12D/WT ; p53 flox/flox mice as described previously (Winslow et al. 2011) . The Massachusetts Institute of Technology Institutional Animal Care and Use Committee approved all animal studies and procedures. Briefly, lung tumors were initiated via intratracheal delivery of a lentiviral vector expressing Cre recombinase. Primary tumors and metastases were harvested at 6-14 mo post-infection and used to establish cell lines. Each metastasis-derived cell line was matched to its primary tumor-derived cell line based on analysis of the unique lentiviral integration site using Southern blotting or linkermediated PCR. Thus, metastatic primary tumors that had matching secondary lesions could be distinguished from nonmetastatic primary tumors. All cell lines were cultured in complete medium (DMEM with 10% FBS, 50 U/mL penicillin, 50 mg/mL streptomycin). Five T nonMet cell lines (368T1, 393T1, 394T4, 802T4, and 2557T1), six T Met cell lines (373T1, 373T2, 389T2, 393T3, 393T5, and 482T1), and five Met cell lines (373N1, 393N1, 393M1, 482N1, and 482M1) were used for subsequent gene expression analysis and/or functional experiments in this study.
Exon arrays and differential isoform expression detection
Affymetrix GeneChip Mouse Exon 1.0 ST arrays (Gene Expression Omnibus GSE26874) of four T nonMet (368T1, 393T1, 802T4, and 2557T1) and six T Met (373T1, 373T2, 389T2, 393T3, 393T5, and 482T1) cell lines were analyzed for transcriptome-wide isoform switches between groups T nonMet and T Met using the Partek Genomics suite software package (version 6.4) with a custom collection of 345,117 probe sets (;22,000 genes) (Winslow et al. 2011) . In summary, Partek data were post-processed using a custom protocol to rank genes based on a combination of (1) statistical significance in Partek's ANOVA-based test for alternative isoform expression, (2) robustly detectible gene expression in both T nonMet and T Met groups, and (3) significant deviation of probe intensity difference between T nonMet and T Met groups for a single probe set, compared with all probe sets of a given gene. High-ranking genes were then further evaluated by manual examination of probe set-based expression profiles in T nonMet and T Met groups.
FITC gelatin degradation assay
Glass-bottomed 35-mm plates (MatTek) were coated with FITC gelatin as described in Bowden et al. (2001) with some modifications. Briefly, MatTek plates were treated with HCl, followed by 50 mg/mL poly-L-lysine, and then coated with a thin layer of FITC-labeled 0.2% gelatin (Sigma) for 1 h. The gelatin coating was then cross-linked with ice-cold 0.8% glutaraldehyde (Electron Microscopy Sciences)/PBS for 15 min at 4°C and then for 30 min at room temperature. Plates were successively washed in PBS (three times for 5 min each), 5 mg/mL sodium borate in PBS (once for 3 min), and PBS (three times for 5 min each), before being incubated for 30 min with complete tissue culture medium. Cells (8 3 10 4 ) were cultured on the gelatin-coated plates for 72 h and subsequently processed using standard fluorescence microscopy procedures.
Immunofluorescence staining for invadopodia components Cells (8 3 10 4 ) were grown overnight at 37°C on 35-mm MatTek plates coated with either 0.2% FITC-labeled gelatin or 0.2% plain gelatin (Sigma). Cells were then fixed in 3.7% formaldehyde (Electron Microscopy Sciences) in PBS for 20 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min, and blocked with 1% BSA and 1% FBS in PBS. Subsequently cells were stained for immunofluorescence microscopy. Primary antibodies included Tks5 (1:100; Santa Cruz Biotechnology, M300; detects both Tks5 long and Tks5 short ), HA tag (1:100; Cell Signaling, 3724), and cortactin (1:100; Millipore, 4F11). F-actin was stained with phalloidin (Invitrogen).
Live-cell fluorescence microscopy
Cells transfected with a pcDNA3 RFP-b-Actin construct (a generous gift from F. Gertler) were plated on gelatin-coated MatTek dishes in L-15 medium (Leibovitz); placed in an environmental chamber with constant 37°C temperature, CO 2 , and humidity; and imaged every 2.5 min for at least 12 h. The lifetimes of at least 150 invadopodia from three independent measurements per condition were analyzed using ImageJ.
Subcutaneous transplant
Nude mice were injected with 5 3 10 4 T Met cells (393T3 parental cells or 393T3 cells expressing sh1 shRNA against Tks5 long ) resuspended in 100 mL of PBS under the skin on their hind flank. Subcutaneously injected mice were analyzed 8 wk after injection. To quantify lung tumor nodules, all of the visible surface tumors were counted under a dissecting microscope.
Intrasplenic transplant
Nude mice were injected with 5 3 10 4 T Met cells (373T1 parental cells or 373T1 cells expressing sh1 shRNA against Tks5 long ) resuspended in 200 mL of PBS via the spleen, as described previously (Winslow et al. 2011) . Briefly, the animals were given 0.1 mg/kg buprenorphine prior to surgery and anaesthetized with a continuous flow of isoflurane throughout the procedure. Once the animals were under deep anesthesia, the abdominal area was disinfected with betadine and 70% ethanol. The spleen was exposed through a small incision. Cells were injected into the spleen with a single injection using an insulin syringe. Cells were given 10 min to travel through the vasculature to the liver, after which the entire spleen was removed to prevent the formation of a large splenic tumor mass. To remove the spleen, a dissolvable 4-0 suture was tied snugly around the base of the spleen, including the major splenic vasculature, and the spleen was removed. The muscle wall was closed with 4-0 dissolvable sutures, and the skin incision was closed with sterile 7-mm wound clips (Roboz). Intrasplenically injected mice were analyzed 3 wk after injection. Quantification of liver tumor nodules was performed by counting all of the visible surface tumors under a dissecting microscope.
Lentiviral infection of autochthonous mouse model of lung adenocarcinoma
Tumors were initiated by intratracheal infection of mice as described previously (DuPage et al. 2009 ). Lentivirus was produced from 293T cell transfection as described above. Virus was recovered from the supernatant by ultracentrifugation at 25,000 rpm for 90 min and resuspended in an appropriate volume (200-2000 mL) of PBS. A lentiviral dose of 1000-4000 viral particles induced 25-50 lung tumors per mouse and allowed 6 mo of survival after tumor initiation, while a lentiviral dose of 500 viral particles induced ;10 tumors per mouse and allowed 8 mo of survival post-initiation.
Clinical analysis
For TCGA data set, an index of Tks5 isoform expression was calculated by [total Tks5/Tks5 long ] based on RNA-seq alignTks5 isoform expression contributes to metastasis ments of 305 human lung adenocarcinoma samples (see the Supplemental Material for details). A low value of the index represents a high Tks5 long to Tks5 short ratio. x 2 test and Fisher's exact test were performed on patients with stage IA disease (n = 57) and stage III/IV disease (n = 59) using a cutoff of Tks5 isoform index = 3.6.
For the University of Michigan data set, Tks5 long expression and total Tks5 expression were measured by qRT-PCR in 102 primary tumor samples from patients with stage I/II lung adenocarcinoma. Levels of Tks5 short expression were calculated by subtracting Tks5 long expression from total Tks5 expression (see the Supplemental Material for details). Based on expression level, patients were divided into a high-expression group (top two-thirds) and a low-expression group (bottom one-third) for Tks5 long , Tks5 short , total Tks5, or Tks5 long to total Tks5 ratio. Five-year disease-free survival and overall survival were analyzed by Kaplan-Meier curves and log-rank test. Multivariate analysis by the Cox proportional hazard model (adjusted by gender, age, stage, and tumor differentiation state) was performed using a continuous value of Tks5 mRNA level to assess survival results. P-values (two-tailed) of <0.05 were considered statistically significant.
